NEXGEL (NXGL) CEO sells 4,000 shares at $2.50–$2.61 under 10b5‑1
NEXGEL (NXGL) CEO and director Adam R. Levy disclosed open‑market sales executed under a Rule 10b5‑1 trading plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
NEXGEL (NXGL) CEO and director Adam R. Levy disclosed open‑market sales executed under a Rule 10b5‑1 trading plan.
He sold 1,600 shares on 10/02/2025 at $2.5000 per share and 2,400 shares on 10/03/2025 at a weighted average price of $2.5497, with individual trades ranging from $2.5000 to $2.6100. After these transactions, he beneficially owned 371,692 shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,400 | $2.5497 | $6K |
| Sale | Common Stock | 1,600 | $2.50 | $4K |
Footnotes (3)
- F1. The Reporting Person sold these shares pursuant to a Rule 10b5-1 trading plan instituted for tax planning purposes. The shares were originally acquired by the Reporting Person from the Issuer on October 15, 2019
- F2. The Reporting Person sold all 1,600 shares of common stock in the open market at a price of $2.5000 per share.
- F3. Represents the weighted average of open market sale transactions ranging from $2.500 to $2.6100 per share. The Reporting Person undertakes to provide full information regarding the number of shares sold at each separate price sold if requested by the Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did NXGL report?
Were these NXGL insider sales part of a prearranged plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.